Hawkins-Daarud, A., Rockne, R., Corwin, D., Anderson, A., Kinahan, P., & Swanson, K. (2014). PM-04 IN SILICO ANALYSIS OF AVAglio AND RTOG 0825 PHASE III CLINICAL TRIALS SUGGESTS SIGNATURES OF PATIENTS TO RECEIVE BENEFIT FROM COMBINED BEVACIZUMAB AND RADIATION THERAPIES. Oxford University Press.

Hawkins-Daarud, Andrea, Russell Rockne, David Corwin, Alexander Anderson, Paul Kinahan, e Kristin Swanson. PM-04 IN SILICO ANALYSIS OF AVAglio AND RTOG 0825 PHASE III CLINICAL TRIALS SUGGESTS SIGNATURES OF PATIENTS TO RECEIVE BENEFIT FROM COMBINED BEVACIZUMAB AND RADIATION THERAPIES. Oxford University Press, 2014.

Hawkins-Daarud, Andrea, et al. PM-04 IN SILICO ANALYSIS OF AVAglio AND RTOG 0825 PHASE III CLINICAL TRIALS SUGGESTS SIGNATURES OF PATIENTS TO RECEIVE BENEFIT FROM COMBINED BEVACIZUMAB AND RADIATION THERAPIES. Oxford University Press, 2014.